ApoB vs. LDL-C: the number to actually watch
Standard panels report LDL-C, but ApoB counts the particles that drive artery disease. Why the distinction matters for APOE4 carriers, and how to get and read it.
By the OutliveAPOE4 editorial team. How we research & source.
If APOE4 nudges your cardiovascular risk, your lipid panel is one of your most useful instruments, and the most famous number on it may be the wrong one to track. LDL-C is what your doctor reads out by default. ApoB is what a growing number of lipid specialists now treat as the truer signal, because it counts the thing that actually clogs arteries. For a carrier, that difference can be the gap between “your numbers look fine” and a real, hidden risk.
The trucks, not the tonnage
Cholesterol does not float freely in your blood. It rides inside particles. The dangerous ones, the atherogenic particles that lodge in artery walls and drive atherosclerosis, each carry exactly one molecule of a protein called apolipoprotein B (ApoB). That covers LDL plus several relatives (VLDL, IDL, and Lp(a)).
That one-protein-per-particle fact is the whole trick:
- LDL-C measures the cholesterol mass packed inside your LDL particles.
- ApoB counts the actual number of atherogenic particles, because there is one ApoB per particle.
Picture a highway. LDL-C tells you the total cargo being hauled. ApoB counts the trucks. It is the trucks bumping into and burrowing through the artery wall that cause the disease, and a road jammed with many small trucks is more dangerous than one with a few big ones, even when the total tonnage is identical. Watch the units, because they trip people up: ApoB is reported in mg/dL in the US and g/L elsewhere (80 mg/dL is the same as 0.80 g/L).
Why the two numbers disagree
Here is the part that makes ApoB worth the trouble. Two people can have the same LDL-C but a different number of particles. When those two measures point in different directions, it is called discordance, and when they disagree, the particle count (ApoB) is the better predictor of risk.
The mechanism is simple. When particles are small and dense, each one carries less cholesterol. So a perfectly normal-looking cholesterol mass can hide a high truck count. Discordance is especially common in people with high triglycerides, insulin resistance, or metabolic syndrome, where ApoB runs elevated relative to LDL-C in a large share of people. That is exactly the profile many carriers and midlife adults drift into, which is how LDL-C ends up quietly understating real risk.
Why this matters specifically for APOE4
APOE4 is associated, on average, with altered lipid handling and a tendency toward higher LDL and ApoB (the full mechanism is in the cholesterol and heart pillar). Cardiovascular risk is one of the most measurable and treatable levers a carrier has, so it is worth measuring it correctly. An ApoB that is higher than your LDL-C would suggest is precisely the kind of hidden risk worth surfacing, rather than finding out the hard way.
How to get it and read it
- Ask for it. It is a standard, inexpensive blood test, but it is often not ordered by default, and coverage varies. Adding ApoB to your panel is usually as simple as asking.
- No ApoB available? Use non-HDL cholesterol. That is total minus HDL, a free number already on your panel. It captures all the atherogenic cholesterol and does not require fasting, so it is a strong fallback.
- Re-test after changes. Lipids stabilize within about 4 to 6 weeks of a diet, exercise, or medication change, so a follow-up panel tells you whether it worked. Watch the trend, not a single reading.
The targets below are orientation, not numbers to chase alone. Guidelines and specialists vary, and your personal goal depends on your overall risk, so treat these as conversation starters with your clinician.
| Risk level | ApoB goal | Matching non-HDL goal |
|---|---|---|
| General / average risk | under ~90 mg/dL | under ~130 mg/dL |
| Higher cardiovascular risk | under 80 mg/dL | under ~100 mg/dL |
| Highest risk | under 65 to 70 (some toward 60) | n/a (driven by ApoB/LDL targets) |
Common questions
Should every APOE4 carrier get an ApoB test? It is a reasonable thing to ask for, especially if you have high triglycerides or metabolic risk, where LDL-C is most likely to mislead. At minimum, look at non-HDL on the panel you already have.
My LDL-C is normal but my doctor seems concerned. Why? Probably discordance. Your particle count (ApoB) may be higher than the cholesterol mass suggests. That gap is the entire reason ApoB exists as a measure.
Is ApoB the same as Lp(a)? No. Lp(a) is one specific, inherited atherogenic particle worth checking once. ApoB counts the whole atherogenic population. Both can matter, and they answer different questions (see lipoprotein(a) and APOE4).
The value of ApoB is that it gives you and your clinician a clearer signal to act on, so use it that way rather than as a number to chase alone. This is general education, not medical advice.
Sources & further reading
Related deep dives
- APOE4, cholesterol, and cardiovascular risk APOE4 does not only affect the brain. It shapes how your body handles cholesterol, which makes cardiovascular health the most concrete, trackable, and treatable lever carriers have.
- Blood pressure and brain health High blood pressure is one of the best-established modifiable risk factors for dementia. Why it matters so much for APOE4 carriers, the numbers, and how to keep it in range.
- Metabolic health, insulin resistance, and the APOE4 brain Blood sugar control is not only a diabetes issue. It is increasingly tied to brain health. What insulin resistance has to do with cognitive risk, the markers to watch, and what helps.